Shares of BridgeBio Pharma (NASDAQ:BBIO), currently valued at $5.88 billion, witnessed an uptick as Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target to $49 from $48 while ...
Quantum Circuits, Inc., announced that its partner Algorithmiq, a European quantum algorithm company focused on life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback